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Background
Analysis of immunoglobulin (Ig) VH and VL genes
derived from sorted single B cells is a powerful technology
for definition of Ig repertoires to viral infections. The pur-
pose of this study was to characterize the Ig repertoire of
plasma cells/plasmablasts (PCs) in subjects early on after
HIV transmission.
Methods
Blood PCs from three AHI subjects obtained approxi-
mately 17, 20 and 30 days after HIV-1 transmission were
sorted into 96-well plates for amplification of VH and VL
genes by RT/PCR. The isolated VH and VL genes were
expressed as recombinant IgG1 mAbs in 293T cells by
transfection using linear Ig expression cassettes, The spe-
cificity of produced mAbs was determined by ELISA and
luminex bead immunoassays against a panel of HIV-1 and
non-HIV-1 antigens.
Results
The number of circulating plasma cells ranged from 1.9%
to 21.0%. When HIV antibodies were detected in subject
plasma, only antibodies to Env gp41 were present. A total
of 787 Ig VH and VL gene pairs were expressed as whole
IgG1 antibodies. HIV-specific antibodies accounted for
only 6.5% of expressed antibodies (range 1.7% to 19%).
All HIV-1 antibodies were against gp41 with no antibod-
ies reacting with any other HIV-1 proteins. Non-HIV-1
antibodies identified from AHI PCs included those
against influenza (0.6%), tetanus toxoid (1.9%), cardioli-
pin (0.8%), Cryptococcus (0.9%), Candida (0.5%), Hep-
2 epithelial cells (5.2%), gut flora (1.7%), lipid A (0.6%)
and unknown (79.3%).
Conclusion
While the initial plasma cell response to influenza vacci-
nation was primarily antigen specific against hemaggluti-
nin, the initial plasma cell response to HIV-1 was
primarily polyclonal with massive expansion of non-HIV
antibodies. The extraordinary degree of polyclonal B cell
activation as early as 17 days after transmission is in part
responsible for the ineffective initial antibody response to
transmitted HIV.
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